Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters

Therapeutic Methods and Therapies TCIM
Database
Publication year range
1.
Bull Exp Biol Med ; 145(2): 252-5, 2008 Feb.
Article in English | MEDLINE | ID: mdl-19023982

ABSTRACT

Experiments on animals with Lewis lung carcinoma and Ehrlich tumor showed that licorice (glycyrrhiza) extract and glyciram prepared from this plant improved the antitumor effect of cyclophosphamide. Glyciram reduced the toxic effect of the cytostatic on peripheral blood leukocytes. Licorice extract inhibited the growth of Ehrlich tumor and development of metastases in mice with Lewis lung carcinoma. Glyciram administered to mice after removal of Lewis lung carcinoma produced an antimetastatic effect and prevented relapses.


Subject(s)
Antineoplastic Agents/therapeutic use , Carcinoma, Ehrlich Tumor/drug therapy , Carcinoma, Ehrlich Tumor/surgery , Carcinoma, Lewis Lung/drug therapy , Carcinoma, Lewis Lung/surgery , Glycyrrhiza/chemistry , Neoplasm Transplantation , Animals , Carcinoma, Ehrlich Tumor/pathology , Carcinoma, Lewis Lung/pathology , Female , Glycyrrhetinic Acid/therapeutic use , Mice , Mice, Inbred C57BL , Mice, Inbred CBA , Neoplasm Metastasis/drug therapy , Plant Extracts/therapeutic use
2.
J Pharmacobiodyn ; 5(6): 439-44, 1982 Jun.
Article in English | MEDLINE | ID: mdl-6889646

ABSTRACT

Augmentation of antitumor activity by combined in situ freeze-destruction of tumor (cryosurgery) and administration of antitumor active substances isolated from a hot water extract of an edible mushroom, Flammulina velutipes (Curt. ex Fr.) SING., was investigated in sarcoma 180 bearing ICR mice. Antitumor active substances of the mushroom included beta-(1,3)-glucan (EA3) and protein-bound polysaccharide (EA6). Antitumor activity was evaluated by the growth rate of the solid tumor rechallenged subcutaneously (s.c.) or by cumulative mortalities of the mice rechallenged intraperitoneally (i.p.) with the ascites tumor, on day 7 after cryosurgery. Weak antitumor effect induced by cryosurgery against challenged solid tumor of sarcoma 180 was markedly augmented by i.p. administration of EA6 (10 mg/kg). Cryosurgery of the solid sarcoma 180 apparently did not induce any antitumor effect against challenged ascites sarcoma 180. However, when cryosurgery was combined with oral administration of the polysaccharides (50 mg/kg), prolonged survival of the mice challenged with ascites sarcoma 180 i.p. was recognized by EA6, but not by EA3. Timing of the administration of EA6 (i.p.) with cryosurgery was best in pre- and post-cryosurgery. Immunological activity of EA6 to the host was discussed.


Subject(s)
Antineoplastic Agents/therapeutic use , Polysaccharides/therapeutic use , Proteoglycans/therapeutic use , Sarcoma 180/therapy , Agaricales , Animals , Carcinoma, Ehrlich Tumor/drug therapy , Carcinoma, Ehrlich Tumor/surgery , Carcinoma, Ehrlich Tumor/therapy , Cryosurgery , Female , Mice , Mice, Inbred ICR , Neoplasm Transplantation , Sarcoma 180/drug therapy , Sarcoma 180/surgery , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL